Jonathan Rubin, MD, MBA

Supernus Pharmaceuticals, Inc., Rockville, Maryland

JCP
Viloxazine ER in Adults With ADHD and Depression and/or Anxiety Symptoms
Original Research

May 27, 2026

Viloxazine ER was well tolerated and associated with improvements in ADHD, depression, and anxiety symptoms in this real-world study.
, , , et al

Insightful. Evidence-based. Human-centered.

Listen to the JCP Podcast Now
Figure: Digital illustration shows a human head with neural connections and podcast title over a dark blue patterned background.

Subscribe to read
more articles

Subscribe